In8 Bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
INAB on Nasdaq
Location
Empire State Building, 350 5 Th Avenue, Suite 5330, New York, NY

There are no Buy or Sell transactions made by insiders since 10/13/2024

In8 Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William Tai-Wei Ho PRESIDENT AND CEO, Director, 10%+ Owner $2.42M Apr 27, 2025
Leslie W. Kreis 10%+ Owner $1.29M May 2, 2025
Aaron G.L. Fletcher 10%+ Owner $1.29M May 2, 2025
Peter C. Brandt Director $141K May 8, 2025
Alan S. Roemer Director $73.5K May 8, 2025
Patrick McCall Chief Financial Officer $12.4K Apr 27, 2025
Kate Rochlin Chief Operating Officer $10.2K Apr 27, 2025
Trishna Goswami Chief Medical Officer $6.39K Sep 4, 2024
Emily Fairbairn Director May 8, 2025
Jeremy R. Graff Director May 8, 2025
Luba Greenwood Director May 8, 2025
Lawrence Lamb EVP and CSO Apr 27, 2025
Melissa Beelen VP, Clinical Operation Jul 29, 2021
Bios Equity Partners, LP 10%+ Owner Aug 13, 2021
Bios Clinical Opportunity Fund, LP 10%+ Owner Dec 13, 2023
Corinne Epperly Director May 8, 2025
Travis Whitfill Director Dec 19, 2024

Recent Insider Transactions by Companies or Individuals for In8 Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.